EydisBio
Business Services · North Carolina, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
201 W Main St Ste 317, Durham, North Car...Website
www.eydisbio.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About EydisBio
EydisBio is a biotech startup based in Durham, NC, specializing in the development of highly selective small molecule kinase inhibitors targeting autoimmune and inflammatory diseases. Their primary focus is on creating a novel TAK1 inhibitor that is orally bioavailable, aimed at providing safer and more effective treatments for conditions such as rheumatoid arthritis, chronic pain, and systemic sclerosis. The company addresses significant unmet medical needs, particularly for patients seeking alternatives to existing anti-TNF biologics. EydisBio's innovative approach leverages a unique discovery platform to develop a pipeline of small molecules that target disease-driving proteins.Explore more
EydisBio Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is EydisBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when EydisBio launches new products
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at EydisBio
Check if EydisBio has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on EydisBio recently announced quarterly report
EydisBio, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once EydisBio has new funding data
Click to see if EydisBio had a recent Job posting/layoffs
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if EydisBio is spiking on competitors!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 2 more new buyers
Compare Similar Companies to EydisBio
Compare insights from companies similar to EydisBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
EydisBio is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
EydisBio is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about EydisBio.
EydisBio financials insights
Gather financial insights about EydisBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Other Financing Round
$17M
EydisBio Tech Stack
A closer look at the technologies used by EydisBio
Most Recent Scoops
Event
Product Marketing, Events, Research & Development, Sales, Search, Software, Field /Outside Sales, Artificial Intelligence, Field Marketing
Funding
Project
Spending/Investment, Funding
Funding
Project
Spending/Investment, Funding
Funding
Funding
EydisBio News & Media
EydisBio Receives FDA Orphan Drug Designation for TAK1 Inhibitor for the Treatment of Systemic Sclerosis
DURHAM, N.C., Sept. 25, 2024 /PRNewswire/ -- EydisBio, Inc. is pleased to announce that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation to EYD-001, its highly selective and potent, orally bioavailable TAK1 inhibitor for the treatment of systemic sclerosis....EydisBio Awarded $2.6 Million Grant to Advance TAK1 Inhibitor Program for Systemic Sclerosis
DURHAM, N.C., Aug. 28, 2024 /PRNewswire/ -- EydisBio, an early-stage pharmaceutical company leveraging a novel approach to treating various autoimmune and inflammatory diseases, is thrilled to announce that it has been awarded a $2.6 million Phase 2 Small Business Innovation Research...
Read more news
Top Business Services Companies
See more top companies
Frequently Asked Questions Regarding EydisBio
Sign Up For FreeTo access detailed company insights
EydisBio is a biotech startup based in Durham, NC, specializing in the development of highly selective small molecule kinase inhibitors targeting autoimmune and inflammatory diseases. Their primary focus is on creating a novel TAK1 inhibitor that is orally bioavailable, aimed at providing safer and more effective treatments for conditions such as r... Read More
